These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19442080)

  • 1. Unraveling progesterone-induced molecular mechanisms in physiological and pathological conditions.
    Rocha A; Soares R
    Curr Clin Pharmacol; 2009 May; 4(2):148-53. PubMed ID: 19442080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
    Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
    Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone and breast cancer.
    Lange CA; Yee D
    Womens Health (Lond); 2008 Mar; 4(2):151-62. PubMed ID: 19072517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative roles of nuclear and membrane-bound progesterone receptors in the female reproductive tract.
    Kowalik MK; Rekawiecki R; Kotwica J
    Reprod Biol; 2013 Dec; 13(4):279-89. PubMed ID: 24287036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
    Bray JD; Jelinsky S; Ghatge R; Bray JA; Tunkey C; Saraf K; Jacobsen BM; Richer JK; Brown EL; Winneker RC; Horwitz KB; Lyttle CR
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):328-41. PubMed ID: 16157482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestins and neuroprotection: are all progestins created equal?
    Singh M
    Minerva Endocrinol; 2007 Jun; 32(2):95-102. PubMed ID: 17557035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental profiles of progesterone receptor transcripts and molecular responses to gestagen exposure during Silurana tropicalis early development.
    Thomson P; Langlois VS
    Gen Comp Endocrinol; 2018 Sep; 265():4-14. PubMed ID: 29778442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure and function of progesterone receptors in breast cancer.
    Horwitz KB
    J Steroid Biochem; 1987; 27(1-3):447-57. PubMed ID: 3320537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic-nuclear trafficking of progesterone receptor. In vivo study of the mechanism of action of antiprogestins.
    Guiochon-Mantel A; Delabre K; Lescop P; Perrot-Applanat M; Milgrom E
    Biochem Pharmacol; 1994 Jan; 47(1):21-4. PubMed ID: 8311841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
    Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
    Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestin activation of nongenomic pathways via cross talk of progesterone receptor with estrogen receptor beta induces proliferation of endometrial stromal cells.
    Vallejo G; Ballaré C; Barañao JL; Beato M; Saragüeta P
    Mol Endocrinol; 2005 Dec; 19(12):3023-37. PubMed ID: 16020483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying progesterone-induced cytoplasmic retention of p27 in breast cancer cells.
    Wang HC; Lee WS
    J Steroid Biochem Mol Biol; 2018 Oct; 183():202-209. PubMed ID: 29959971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacodynamics and safety of progesterone.
    Piette PCM
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():13-29. PubMed ID: 32739288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor isoforms in normal and malignant breast.
    Mote PA; Graham JD; Clarke CL
    Ernst Schering Found Symp Proc; 2007; (1):77-107. PubMed ID: 18540569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
    Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
    Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity of progesterone's actions and receptors in the mammalian ovary.
    Peluso JJ
    Biol Reprod; 2006 Jul; 75(1):2-8. PubMed ID: 16452458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity binding of [3H]R5020 and [3H]progesterone by putative progesterone receptors in cytosol and nuclear extract of turtle oviduct.
    Ho SM; Callard IP
    Endocrinology; 1984 Jan; 114(1):70-9. PubMed ID: 6537807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine signaling by progesterone.
    Rajaram RD; Brisken C
    Mol Cell Endocrinol; 2012 Jun; 357(1-2):80-90. PubMed ID: 21945477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gene expression by progesterone in cancer cells: effects on cyclin D1, EGFR and VEGF.
    Hernández-Hernández OT; Camacho-Arroyo I
    Mini Rev Med Chem; 2013 Apr; 13(5):635-42. PubMed ID: 23432380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.